Search results
Results From The WOW.Com Content Network
Restylane. Restylane is the trade name for a range of injectable fillers with a specific formulation of non-animal sourced hyaluronic acid (HA). In the United States, Restylane was the first hyaluronic acid filler to be approved by the U.S. Food and Drug Administration (FDA) for cosmetic injection into subdermal facial tissues.
Cosmetic injectables are on the rise and with them, telltale side effects like swelling, redness, and bruising. But the right post-injection skincare can help. The Expert Guide to Caring for Your ...
Injectable filler (injectable cosmetic filler, injectable facial filler) is a soft tissue filler made of polysaccharides injected into the skin at different depths. They help fill in facial wrinkles, provide facial volume, and augment facial features. Side effects include bruising or infections from improper sterilisation.
Botulinum toxin produced by Clostridium botulinum (an anaerobic, gram-positive bacterium) is the cause of botulism. [ 25] Humans most commonly ingest the toxin from eating improperly canned foods in which C. botulinum has grown. However, the toxin can also be introduced through an infected wound.
The main purpose of under-eye filler is to give your eyes a smoother, more radiant, and more “awake” look. “These fillers address issues like hollowing and volume loss, which improves the ...
“This is when dermal filler migrates from the injection site to another part of the face,” says Dr. Michael Horn, M.D., a Chicago-based board-certified plastic surgeon. “Though this ...
Lip augmentation is a cosmetic procedure that modifies the shape of the lips using fillers, such as collagen or implants. The procedure may be performed to increase lip size, correct asymmetry, create protrusion, or adjust the ratio of the top and bottom lips. The procedure typically involves surgical injection, though temporary non-surgical ...
Artefill. Artefill is a permanent injectable wrinkle filler, for the correction of smile lines. Artefill was approved by the U.S. Food and Drug Administration (FDA) as a medical device in October 2006. A prior version of the product called Artecoll has been marketed in Canada and Europe since the 1990s.